Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) will speak at the 28th Annual JP Morgan Healthcare Conference on Wednesday, January 13. The conference is being held at the Westin St. Francis Hotel in San Francisco, California. Speaking for the company will be Optimer President and Chief Executive Officer Michael Change.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The presentation will be broadcasted live on the company’s website, http://www.otpimerpharma.com/. The webcast will be on the investors page of the website. Following the conclusion of the event, the webcast will remain on the site for thirty days as a replay.
Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. The Company’s development efforts are focused on products that treat gastrointestinal infections, and related diseases where therapies have limitations. It has two late-stage anti-infective product candidates: fidaxomicin (formerly OPT-80) and prulifloxacin. Fidaxomicin, the Company’s lead product candidate, is an antibiotic in its second Phase III registration trial for the treatment of Clostridium difficile-infections (CDI), the common nosocomial, or hospital acquired diarrhea. Prulifloxacin is a prodrug in the fluoroquinolone class of antibiotics. The Company is developing additional product candidates using its technology, including its Optimer One-Pot Synthesis (OPopS) drug discovery platform. OPopS is a computer-aided technology that enables the rapid and low-cost synthesis of an array of carbohydrate-based compounds.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
